SCHEMBL26699083

SCHEMBL26699083

CSc1c(C)[nH]c(-c2cc(Cl)c(C(C)(C)C)cc2C)cc1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26601710 0.84 — —
SCHEMBL26601879 0.84 — —
SCHEMBL26701086 0.84 — —
SCHEMBL26601568 0.80 MAPK1 (0.34) —
SCHEMBL26701210 0.78 ADORA2A (0.30) —
SCHEMBL26601569 0.78 — —
SCHEMBL26601575 0.78 — —
SCHEMBL26601571 0.78 — —
SCHEMBL26701304 0.78 — —
SCHEMBL26699086 0.74 GRIN2D (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023205465-A1 HETEROARYL COMPOUNDS FOR THE TREATMENT OF PAIN VERTEX PHARMACEUTICALS INCORPORATED (US) 2023-10-26 — — WO disclosed
Send feedback